**Glucotrack Receives Notice from Nasdaq Regarding Bid Price Rule Compliance**Washington, D.C., December 31, 2024 – Glucotrack, Inc. (NASDAQ: GCTK) recently received notification from the Nasdaq Stock Market LLC (“Nasdaq”) concerning its bid price fo
* This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read GlucoTrack’s 8K filing here. About GlucoTrack (Get Free Report) GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the […]
More Stories
House Passes Elections Bill Requiring Proof of Citizenship, Voter ID
By Nathan Worcester WASHINGTON—The SAVE America Act passed the House on Feb. 11. Led by Rep. Chip Roy (R-Texas), the...
Super Bowl LX Ratings Mirage: NFL and Networks Peddle Success Myth Amid Viewership Plunge
By Stephen Zogopoulos, USNN World News February 14, 2026 – In the aftermath of Super Bowl LX, where the Seattle...
Automakers Pump Brakes on EV Investment as Federal Subsidies Stop
By Kevin Stocklin A few years ago, U.S. auto executives were hailing their conversion to electric cars and market analysts...
Massive Sinkhole Opens Up on Street in China
By Dorothy Li A large sinkhole has opened on a street in Shanghai, swallowing a section of the road and...
Share of New Homes Selling at a Discount Outpaces Existing Homes for First Time
By Mary Prenon Nearly 20 percent of newly constructed homes across the United States experienced price cuts in late 2025,...
Prairie Power Shift: Four Western Provinces Forge Path to U.S. Statehood
By Stephen Zogopoulos, USNN World News In a bold and unprecedented move that could reshape North America’s political landscape, the...